Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.EC approves BMS melanoma drug Opdivo two and four-week flat dosing schedule
Image: The EC has approved BMS melanoma drug Opdivo two and four-week flat dosing schedule. Photo: courtesy of Rept0n1x.
Image: The EC has approved BMS melanoma drug Opdivo two and four-week flat dosing schedule. Photo: courtesy of Rept0n1x.